Therapy Areas: Vaccines
Arcturus Receives Regulatory Approval to Proceed with Phase 2 Study of ARCT-810 mRNA Therapeutic Candidate for Ornithine Transcarbamylase Deficiency
29 July 2021 - - US-based clinical-stage messenger RNA medicines company Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) has received approval from the UK Health Research Authority to initiate a Ph...
Touchlight, Vanderbilt University Medical Center Collaborate on DARPA Pandemic Prevention Platform Programme
29 July 2021 - - UK-based synthetic DNA manufacturer Touchlight is collaborating with the Vanderbilt Vaccine Center at Vanderbilt University Medical Center as part of the DARPA P3 programme, the compa...
Vivera expands access to COVID-19 testing, vaccines and PPE under new safety protocols across the US
29 July 2021 - Pharmaceutical company Vivera Pharmaceuticals Inc Wednesday expanded access to testing resources, vaccine clinics and personal protective equipment (PPE) following the new mask and test...
US FDA extends shelf life of J&J's COVID-19 vaccine to six months
29 July 2021 - The US Food & Drug Administration (FDA) has extended the shelf life for US pharmaceutical company Johnson & Johnson's (NYSE:JNJ) single-shot COVID-19 vaccine to six months ...
Cogitativo identifies top ten L.A. County communities at greatest risk as COVID-19 cases & Delta variant spreads
29 July 2021 - Data science company Cogitativo Inc on Wednesday announced the "Surge Centers: The Top 10 L.A. County Neighborhoods at Greatest Risk as COVID Infections Rise " report that ide...
New Zealand gives provisional approval for AstraZeneca's COVID-19 vaccine
29 July 2021 - Medsafe, the health regulator of New Zealand, has granted provisional approval for the AstraZeneca (LON:AZN) COVID-19 vaccine for individuals aged 18 years and older, Reuters news agenc...